Aycan and Chimaera GmbH received U.S. Food and Drug Administration (FDA) 510(k) clearance of Chimaera FusionSync, a software tool for more efficient handling and diagnosis of multi-modal and follow-up medical data. Available with Aycan workstation OsiriX Pro, Chimaera FusionSync was launched in Europe in 2013 with CE marking.

Barco announced the launch of Eonis 24” – a 24-inch clinical display, which comes either standard (black) or with a fully cleanable front glass panel (white). The 24” is designed to provide healthcare specialists with consistent image quality and healthcare IT professionals with management tools for centrally controlling their clinical display fleet.

Agfa HealthCare teamed with Dell to integrate Agfa’s ICIS platform with Dell Drive Plus to offer medical image management within an Epic or other electronic health record (EHR). Highlighted in conjunction with the HIMSS 2014 annual conference, the collaboration is part of Agfa HealthCare’s and Dell’s focus to streamline customer workflows by providing easily integrated enhancements for the EHR, including seamless access to medical images within a patient’s electronic health record.

Agfa HealthCare unveiled enhancements to its ICIS at the 2014 annual meeting of the Health Information and Management Systems Society (HIMSS).

March 3, 2014 — Biotronik announced the release of its Passeo-18 Lux drug-releasing balloon (DRB) in all countries accepting CE mark, following recent approval.

Royal Philips’s IntelliSpace Portal was named a Category Leader in Enterprise Advanced Visualization Software in the 2013 Best in KLAS: Software and Services report. 

March 3, 2014 — OrbusNeich announced that patient enrollment has initiated in Japan in the pivotal clinical trial of the Combo dual-therapy stent, employing a single Japan-U.S. protocol conducted as a global clinical trial “proof-of-concept” under the framework of the joint Japan-U.S. Harmonization-By-Doing [HBD] initiative.

Evena Medical, a developer of high-definition imaging for precision venous access, announced an agreement with a major distribution partner to distribute its products in 15 countries in the Middle East and North Africa. Evena also received a $5 million tranche of the company’s planned $15 million Series B financing. Evena featured its Eyes-On Glasses at HIMSS14 in Orlando, Fla.

Subscribe Now